1,306.69 USD
↗ 35.94 (2.83%)AT CLOSE (03:59 PM EDT)
Eli Lilly & Co.
LLYNYSE • USD
1,306.20
↘ 0.49 (0.04%)
POST MARKET (AS OF 06:18 PM EDT)
Post Market
AS OF 06:18 PM EDT
1,306.20
↘ 0.49 (0.04%)
Market: OPEN
Shares of Eli Lilly & Co. (LLY) are trading at $1,306.20. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. This is driven by a robust Altman Z-Score, exceptional Return on Equity (78.8%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 22, 2026.
Open?$1,281.76
High?$1,321.21
Low?$1,275.10
Prev. Close?$1,270.75
Volume?2.7M
Avg. Volume?2.3M
VWAP?$1,306.86
Rel. Volume?1.16x
Bid / Ask
Bid?$1,304.15 × 80
Ask?$1,308.40 × 40
Spread?$4.25
Midpoint?$1,306.28
Valuation & Ratios
Market Cap?1132.7B
Shares Out?941.4M
Float?849.7M
Float %?90.3%
P/E Ratio?42.41
P/B Ratio?33.43
EPS?$29.97
Dividend?0.51%
Ex-Dividend?N/A
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
1132.7B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?60
Short Sent.?69
Piotroski F-Score?6/9Mixed
Altman Z-Score?8.07Safe
Confidence?73%Moderate
Short InterestLow
Short % of Float?0.83%Low
Short Interest?7.0M
Days to Cover?2.9
Free Float849.7M
Avg Daily Volume2.4M
Settlement Date2026-09-30
Financial Health
Current Ratio?1.35Adequate
Quick Ratio?1.00Adequate
Cash Ratio?0.19Low
Debt/Equity?1.62High
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?42.4PRICEY▾
Peers40
S&P17
P/B?33.43HIGH▾
Peers10
S&P3
P/S?14.22HIGH▾
Peers20
S&P3
P/FCF?62.3PRICEY▾
Peers10
S&P7
EV/EBITDA?28.3HIGH▾
Peers20
S&P12
EV/Sales?14.79HIGH▾
Peers20
S&P3
Returns & Efficiency
ROE?78.8%STRONG▾
Peers89
S&P97
ROA?18.8%STRONG▾
Peers80
S&P93
Cash Flow & Enterprise
FCF?$18.2B
Enterprise Value?$1178.6B
Fundamentals ratios updated end of day